ICICI Prudential Nifty Pharma Index Fund
Direct · Growth ₹20.00
06 Jul 2026
NAV
22.7%
3Y CAGR
23.0%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
10.16
Sharpe
-16.6%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.88 L | 23.4% | -13.5% | 73.5% |
| 3 Years | ₹36.00 L | ₹44.34 L | 14.7% | 9.0% | 18.9% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 23.4% | 14.5% | 9.1% | +8.9% |
| 3 Years | 14.7% | 11.2% | 13.0% | +3.6% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 23.8% | 14.9% | -8.4% | 63.1% | 0.83 | 4.79 | 89% | — | — |
| 3 Years | 22.7% | 22.5% | 19.4% | 26.9% | 10.16 | — | 100% | — | — |
-16.6%
Max Drawdown
5 mo
Drawdown Duration
14 mo
Recovery Time
-4.1%
Avg Drawdown
Calmar Ratio by Duration
1.44
1Y
1.37
3Y
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +14.72 | 0.57 | 72.9% | 51.0% | 15.6% | -3.4% |
| 3 Years | +15.50 | 0.58 | 75.6% | 52.7% | 22.1% | 6.7% |
| 5 Years | +9.35 | 0.56 | 71.5% | 49.8% | 15.5% | 5.8% |
| 7 Years | +5.65 | 0.56 | 71.5% | 49.8% | 10.8% | 4.1% |
| 10 Years | +2.98 | 0.56 | 71.5% | 49.8% | 7.5% | 2.9% |
| 12 Years | +1.97 | 0.56 | 71.5% | 49.8% | 6.2% | 2.4% |
| 15 Years | +0.98 | 0.56 | 71.5% | 49.8% | 4.9% | 1.9% |
19
Total Holdings
77.7%
Top 10 Weight
1
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. | 21.33% |
| 2 | Divi's Laboratories Ltd. | 9.48% |
| 3 | Dr. Reddy's Laboratories Ltd. | 8.89% |
| 4 | Cipla Ltd. | 8.83% |
| 5 | Lupin Ltd. | 6.16% |
| 6 | Laurus Labs Ltd. | 5.93% |
| 7 | Torrent Pharmaceuticals Ltd. | 5.16% |
| 8 | Aurobindo Pharma Ltd. | 4.46% |
| 9 | Glenmark Pharmaceuticals Ltd. | 3.83% |
| 10 | Alkem Laboratories Ltd. | 3.60% |